These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37839675)
21. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related]
22. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. Pollyea DA; Altman JK; Assi R; Bixby D; Fathi AT; Foran JM; Gojo I; Hall AC; Jonas BA; Kishtagari A; Lancet J; Maness L; Mangan J; Mannis G; Marcucci G; Mims A; Moriarty K; Mustafa Ali M; Neff J; Nejati R; Olin R; Percival ME; Perl A; Przespolewski A; Rao D; Ravandi F; Shallis R; Shami PJ; Stein E; Stone RM; Sweet K; Thota S; Uy G; Vachhani P; Cassara CJ; Freedman-Cass DA; Stehman K J Natl Compr Canc Netw; 2023 May; 21(5):503-513. PubMed ID: 37156478 [TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Tzankov A; Hebeda K; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U Ann Hematol; 2017 May; 96(5):765-777. PubMed ID: 28191591 [TBL] [Abstract][Full Text] [Related]
24. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Beird HC; Khan M; Wang F; Alfayez M; Cai T; Zhao L; Khoury J; Futreal PA; Konopleva M; Pemmaraju N Blood Cancer J; 2019 Dec; 9(12):99. PubMed ID: 31811114 [TBL] [Abstract][Full Text] [Related]
25. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia. Loghavi S; DiNardo CD; Furudate K; Takahashi K; Tanaka T; Short NJ; Kadia T; Konopleva M; Kanagal-Shamanna R; Farnoud NR; Pierce S; Khoury JD; Jorgensen JL; Patel KP; Daver N; Yilmaz M; Medeiros LJ; Kantarjian H; Ravandi F; Wang SA Br J Haematol; 2021 Mar; 192(6):1054-1063. PubMed ID: 33618432 [TBL] [Abstract][Full Text] [Related]
26. Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin. Griffin GK; Booth CAG; Togami K; Chung SS; Ssozi D; Verga JA; Bouyssou JM; Lee YS; Shanmugam V; Hornick JL; LeBoeuf NR; Morgan EA; Bernstein BE; Hovestadt V; van Galen P; Lane AA Nature; 2023 Jun; 618(7966):834-841. PubMed ID: 37286599 [TBL] [Abstract][Full Text] [Related]
27. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report. Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129 [TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm. Zhang X; Wu Y; Li C; Shen K; Li R Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129 [TBL] [Abstract][Full Text] [Related]
29. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm. Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological analysis of 46 cases with CD4 Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome. Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656 [TBL] [Abstract][Full Text] [Related]
32. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594 [TBL] [Abstract][Full Text] [Related]
33. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review. Paluri R; Nabell L; Borak S; Peker D Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172 [TBL] [Abstract][Full Text] [Related]
34. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. Mason EF; Hasserjian RP; Aggarwal N; Seegmiller AC; Pozdnyakova O Blood Adv; 2019 Nov; 3(21):3322-3332. PubMed ID: 31698462 [TBL] [Abstract][Full Text] [Related]
35. Neoplasms derived from plasmacytoid dendritic cells. Facchetti F; Cigognetti M; Fisogni S; Rossi G; Lonardi S; Vermi W Mod Pathol; 2016 Feb; 29(2):98-111. PubMed ID: 26743477 [TBL] [Abstract][Full Text] [Related]
36. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations. El Hussein S; Wang W Br J Haematol; 2023 Mar; 200(5):545-555. PubMed ID: 36606610 [TBL] [Abstract][Full Text] [Related]
38. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y; Yang J; Lindsey K Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895 [TBL] [Abstract][Full Text] [Related]